Evidence map›Paper›PMID 35953821›Full record

ReviewJournal of nanobiotechnology2022

Black phosphorous nanomaterials as a new paradigm for postoperative tumor treatment regimens.

Yanhua Hou, Yang Fei, Zehong Liu, Yingqi Liu, Menghuan Li, Zhong Luo

Open access · goldAbstract readReview
In one paragraph

Review in Journal of nanobiotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yanhua HouChongqing Engineering Research Center of Pharmaceutical Science, Chongqing Medical and Pharmaceutical College, Chongqing, 401331, China.
Yang FeiSchool of Life Science, Chongqing University, Chongqing, 400044, China.
Zehong LiuChongqing Engineering Research Center of Pharmaceutical Science, Chongqing Medical and Pharmaceutical College, Chongqing, 401331, China.
Yingqi LiuSchool of Life Science, Chongqing University, Chongqing, 400044, China. liuyingqv@cqu.edu.cn.
Menghuan LiSchool of Life Science, Chongqing University, Chongqing, 400044, China. menghuanli@cqu.edu.cn.
Zhong LuoSchool of Life Science, Chongqing University, Chongqing, 400044, China. luozhong918@cqu.edu.cn.
Chongqing University · CNChongqing Medical and Pharmaceutical College · CN

Funding

Chongqing Medical and Pharmaceutical College Research Program ygzcxtd2018A3Chongqing Municipal Education Commission KJQN202102810Chongqing Outstanding Young Talent Supporting Program cstc2021ycjh-bgzxm0124Fundamental Research Funds for the Central Universities 2021CDJLXB001Fundamental Research Funds for the Central Universities 2021CDJZYJH-002National Natural Science Foundation of China 32122048Natural Science Foundation of Chongqing Municipal Government cstc2020jcyj-msxmX0834Returning Overseas Scholar Innovation Program CX2018062Returning Overseas Scholar Innovation Program CX2020045
6 · The paper itself

Abstract

Surgery is currently a mainstream treatment modality for various solid tumor indications. However, aggressive resection of tumor tissues frequently causes postoperative complications, which severely undermine the well-being of patients. Moreover, the residue tumor cells may substantially increase the risk of local and distant tumor relapse. The recent development in black phosphorus (BP)-based nanomaterials offers a promising opportunity to address these clinical challenges. BP is an emerging nanomaterial with excellent biocompatibility and versatile functionality, which has already demonstrated great potential for a variety of biomedical applications including tumor therapy and tissue engineering. In this review, the recent advances in BP-based nanobiomaterials for the post-surgery treatment of solid tumor have been summarized, while specific emphasis was placed on their capability to continuously inhibit residue tumor growth at the surgery site as well as stimulating various healing mechanisms, aiming to preventing tumor relapse while promoting the healing of surgery-induced traumatic soft/hard tissue injuries. It is anticipated that the nanoengineered BP-based materials may open new avenues to tackle those clinical challenges in surgical treatment of solid tumors.

Indexed as

NanostructuresNeoplasmsHumansPhosphorusRecurrencePhosphorusBlack phosphorusPostoperative tumor treatmentTissue reconstructionWound healing

Identifiers

PMID35953821
PMCPMC9367102
OpenAlexW4291020171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.